Tove Agner

17.4k total citations · 1 hit paper
285 papers, 10.9k citations indexed

About

Tove Agner is a scholar working on Dermatology, Immunology and Allergy and Pharmaceutical Science. According to data from OpenAlex, Tove Agner has authored 285 papers receiving a total of 10.9k indexed citations (citations by other indexed papers that have themselves been cited), including 250 papers in Dermatology, 130 papers in Immunology and Allergy and 34 papers in Pharmaceutical Science. Recurrent topics in Tove Agner's work include Contact Dermatitis and Allergies (188 papers), Dermatology and Skin Diseases (155 papers) and Allergic Rhinitis and Sensitization (115 papers). Tove Agner is often cited by papers focused on Contact Dermatitis and Allergies (188 papers), Dermatology and Skin Diseases (155 papers) and Allergic Rhinitis and Sensitization (115 papers). Tove Agner collaborates with scholars based in Denmark, Germany and United Kingdom. Tove Agner's co-authors include Jørgen Serup, Jeanne Duus Johansen, Elisabeth Held, Jaliya Pinnagoda, Torkil Menné, Gregor B. E. Jemec, Dorte W. Ramsing, Maja‐Lisa Clausen, Simon Francis Thomsen and Niels Erik Ebbehøj and has published in prestigious journals such as The Lancet, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Tove Agner

279 papers receiving 10.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Guidelines for transepidermal water loss (TEWL) measurement

1990 885 citations Tove Agner et al. Contact Dermatitis profile →

Peers

Countries citing papers authored by Tove Agner

Since Specialization

Citations

This map shows the geographic impact of Tove Agner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tove Agner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tove Agner more than expected).

Fields of papers citing papers by Tove Agner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tove Agner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tove Agner. The network helps show where Tove Agner may publish in the future.

Co-authorship network of co-authors of Tove Agner

This figure shows the co-authorship network connecting the top 25 collaborators of Tove Agner. A scholar is included among the top collaborators of Tove Agner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tove Agner. Tove Agner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hand eczema and changes in the skin microbiome after 2 weeks of topical corticosteroid treatment 2024 ·Journal of the European Academy of Dermatology and Venereology ·Line Brok Nørreslet, Anna Cäcilia Ingham, Tove Agner, Caroline Meyer Olesen, Anne Bregnhøj, Mette Sommerlund, Paal Skytt Andersen, Marc Stegger, Charlotte G. Mørtz, Sofie Marie Edslev	3
2	Development and Validation of a Patient-Reported Outcome Measure of the Impact of Chronic Hand Eczema on Health-Related Quality of Life: the Hand Eczema Impact Scale (HEIS) 2024 ·Dermatology and Therapy ·Elke Weißhaar, Yasemin Topal Yüksel, Tove Agner, (unknown), Laura Grant, Rob Arbuckle, (unknown), (unknown), (unknown), (unknown), Henrik Thoning, Christian Apfelbacher	3
3	Current frequency of contact allergy to isothiazolinones (methyl‐, benz‐ and octylisothiazolinone) across Europe 2024 ·Contact Dermatitis ·(unknown), Wolfgang Uter, Olivier Aerts, Tove Agner, Richard Brans, M. Bruze, Caterina Foti, Ana M. Giménez‐Arnau, Margarida Gonçalo, Cecilia Svedman, Luca Stingeni, Mark Wilkinson, Jeanne Duus Johansen	8
4	Contact Allergy to Methacrylate Containing Nail Products: Lack of Impact of EU Legislation. An Audit on Behalf of the European Environmental Contact Dermatitis Research Group (EECDRG) 2024 ·Contact Dermatitis ·Mark Wilkinson, Olivier Aerts, Tove Agner, M. Bruze, Richard Brans, Caterina Foti, Ana M. Giménez‐Arnau, Luca Stingeni, Cecilia Svedman	1
5	Prevalence of dermatitis including allergic contact dermatitis from medical devices used by children and adults with Type 1 diabetes mellitus: A systematic review and questionnaire study 2024 ·Journal of the European Academy of Dermatology and Venereology ·Laura B. von Kobyletzki, (unknown), Thanisorn Sukakul, Olivier Aerts, Tove Agner, Timo Buhl, M. Bruze, Caterina Foti, Ana M. Giménez‐Arnau, Margarida Gonçalo, Nils Hamnerius, Jeanne Duus Johansen, Thomas Rustemeyer, Luca Stingeni, Mark Wilkinson, Cecilia Svedman	5
6	Evaluation of validity, reliability and ability to detect change for the Hand Eczema Severity Index ( HECSI ) and evaluation of HECSI ‐75 and HECSI ‐90 as within‐patient responder definitions 2024 ·Contact Dermatitis ·Yasemin Topal Yüksel, Henrik Thoning, (unknown), (unknown), Rob Arbuckle, Laura Grant, Tove Agner	4
7	Demographics, characteristics and medical treatment among adults with hand eczema in Denmark. A cross‐sectional validation and registry‐based study 2023 ·Contact Dermatitis ·(unknown), Yasemin Topal Yüksel, Ida Vittrup, (unknown), (unknown), Line Brok Nørreslet, (unknown), (unknown), Claus Zachariae, Mette Sommerlund, Anne Bregnhøj, Alexander Egeberg, Tove Agner, Simon Francis Thomsen, Jacob P. Thyssen	3
8	Treatment with delgocitinib cream improves itch, pain and other signs and symptoms of chronic hand eczema: Results from the Hand Eczema Symptom Diary in a phase IIb randomized clinical trial 2023 ·Contact Dermatitis ·Andrea Bauer, Jacob P. Thyssen, Timo Buhl, Thor Schütt Svane Nielsen, (unknown), (unknown), Tove Agner	13
9	A nationwide 104 weeks real‐world study of dupilumab in adults with atopic dermatitis: Ineffectiveness in head‐and‐neck dermatitis 2023 ·Journal of the European Academy of Dermatology and Venereology ·Ida Vittrup, Niels Steen Krogh, (unknown), Jesper Elberling, Lone Skov, Kristina Sophie Ibler, Gregor B. E. Jemec, Charlotte G. Mørtz, (unknown), Carsten Bindslev‐Jensen, (unknown), Alexander Egeberg, Tove Agner, Mette Deleuran, Christian Vestergaard, Jacob P. Thyssen	32
10	Prevalence and incidence of hand eczema in healthcare workers: protocol for a systematic review and meta-analysis 2022 ·BMJ Open ·Cara Symanzik, Yasemin Topal Yüksel, (unknown), Jacob P. Thyssen, Christoph Skudlik, Swen Malte John, Richard Brans, Tove Agner	1
11	Temporal and Spatial Variation of the Skin-Associated Bacteria from Healthy Participants and Atopic Dermatitis Patients 2022 ·mSphere ·Christopher J. Barnes, Maja‐Lisa Clausen, Maria E. Asplund, L. Rasmussen, Caroline Meyer Olesen, Yasemin Topal Yüksel, Paal Skytt Andersen, Thomas Litman, Anders J. Hansen, Tove Agner	9
12	Healthcare utilization in Danish children with atopic dermatitis and parental topical corticosteroid phobia 2020 ·Pediatric Allergy and Immunology ·Trine Gerner, (unknown), Christian Vestergaard, Mette Deleuran, Gregor B. E. Jemec, Charlotte G. Mørtz, Tove Agner, Alexander Egeberg, Lone Skov, Jacob P. Thyssen	15
13	Value of photo assessment in late patch test readings—A multicenter study from six European patch test clinics 2020 ·Contact Dermatitis ·Yasemin Topal Yüksel, (unknown), Richard Brans, Cecilia Svedman, Evy Paulsen, Ana M. Giménez‐Arnau, Caterina Foti, Tove Agner, (unknown)	9
14	Dupilumab for prurigo nodularis: Case series and review of the literature 2020 ·Dermatologic Therapy ·Jesper Grønlund Holm, Tove Agner, Carsten Sand, Simon Francis Thomsen	37
15	The Efficacy to Prevent Irritant Hand Eczema: an Overview of the Interventional Procedures 2020 ·Current Treatment Options in Allergy ·(unknown), Tove Agner, Line Brok Nørreslet, (unknown)	1
16	Advancement through epidermis using tape stripping technique and Reflectance Confocal Microscopy 2019 ·Scientific Reports ·Caroline Meyer Olesen, Christine Fuchs, Peter A. Philipsen, Merete Hædersdal, Tove Agner, Maja‐Lisa Clausen	39
17	A job-exposure matrix addressing hand exposure to wet work 2019 ·International Archives of Occupational and Environmental Health ·(unknown), Esben Meulengracht Flachs, Jennifer Astrup Sørensen, Niels Erik Ebbehøj, Jens Peter Bonde, Tove Agner	15
18	The influence of probiotics for preterm neonates on the incidence of atopic dermatitis—results from a historically controlled cohort study 2017 ·Archives of Dermatological Research ·(unknown), Birgitte Smith, Gorm Greisen, Karen A. Krogfelt, Maja‐Lisa Clausen, Tove Agner	12
19	Current knowledge on biomarkers for contact sensitization and allergic contact dermatitis 2017 ·Contact Dermatitis ·Sjors A. Koppes, Kristiane A. Engebretsen, Tove Agner, Irena Angelova‐Fischer, Teresa Løvold Berents, Johanna M. Brandner, Richard Brans, Maja‐Lisa Clausen, Edith Hümmler, Ivone Jakaša, (unknown), Swen Malte John, Denis Khnykin, Sonja Molin, (unknown), Sari Suomela, Hermann‐Josef Thierse, Sanja Kežić, Stefan F. Martin, Jacob P. Thyssen	54
20	Effect of systemic treatment with cholesterol-lowering drugs on the skin barrier function in humans. 1995 ·Acta Dermato Venereologica ·Dorte W. Ramsing, E Agner, J Malinowski, (unknown), Tove Agner	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact